A multi-site case study of community-clinical linkages for promoting HPV vaccination
- PMID: 31158042
- PMCID: PMC6746520
- DOI: 10.1080/21645515.2019.1616501
A multi-site case study of community-clinical linkages for promoting HPV vaccination
Abstract
Human papillomavirus (HPV) vaccination rates in the U.S. are suboptimal, requiring innovative partnerships between community and clinical entities to remedy this issue. A rigorous evaluation of HPV-related community-clinical linkages (CCLs) was conducted to understand their components, processes, and outcomes to increase HPV vaccination. Cancer Prevention and Control Research Network (CPCRN) investigators explored CCLs in their communities employing an iterative, case study approach. Information describing nine CCLs on HPV vaccination was collected from representatives from the community organization and clinical setting. Thematic content analysis was used to analyze and interpret data. Five CCLs included a federally qualified health center as the clinical partner, and five included a non-profit organization as the community partner. Five reflected clinically focused integration wherein engagement occurs in the community but vaccine delivery and follow-up occur in the clinical setting. The main impetus was the need to improve HPV vaccination and a community's strong interest in preventing cancer. Noted critical components were a designated person to support the CCL and funding. Results will guide HPV vaccination promotion, education, and intervention efforts. CCLs provide an opportunity to study the adaption, integration, and enhancement of evidence-based approaches to increase HPV vaccination.
Keywords: Community health services; cervical cancer; community networks; health services; prevention; vaccination.
Similar articles
-
A Qualitative Study of Parental Knowledge and Perceptions of Human Papillomavirus and Cervical Cancer Prevention in Rural Central Java, Indonesia: Understanding Community Readiness for Prevention Interventions.Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2429-2434. doi: 10.31557/APJCP.2019.20.8.2429. Asian Pac J Cancer Prev. 2019. PMID: 31450917 Free PMC article.
-
Perceptions of HPV and cervical cancer among Haitian immigrant women: implications for vaccine acceptability.Educ Health (Abingdon). 2011 Dec;24(3):479. Epub 2011 Dec 7. Educ Health (Abingdon). 2011. PMID: 22267344
-
Racial and Ethnic Group Knowledge, Perceptions and Behaviors about Human Papillomavirus, Human Papillomavirus Vaccination, and Cervical Cancer among Adolescent Females.J Pediatr Adolesc Gynecol. 2016 Oct;29(5):429-435. doi: 10.1016/j.jpag.2016.02.005. Epub 2016 Feb 22. J Pediatr Adolesc Gynecol. 2016. PMID: 26915922 Free PMC article.
-
Overcoming the barriers to HPV vaccination in high-risk populations in the US.Gynecol Oncol. 2010 Jun;117(3):486-90. doi: 10.1016/j.ygyno.2010.02.011. Epub 2010 Mar 29. Gynecol Oncol. 2010. PMID: 20303156 Review.
-
HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe.Hum Vaccin Immunother. 2019;15(7-8):1615-1627. doi: 10.1080/21645515.2018.1564436. Epub 2019 Feb 20. Hum Vaccin Immunother. 2019. PMID: 30633623 Free PMC article.
Cited by
-
Development and Feasibility Testing of the Clinical-Community Linkage Self-Assessment Survey for Community Organizations.Front Public Health. 2022 May 20;10:797468. doi: 10.3389/fpubh.2022.797468. eCollection 2022. Front Public Health. 2022. PMID: 35669755 Free PMC article. Review.
-
Papillomavirus Vaccination Programs and Knowledge Gaps as Barriers to Implementation: A Systematic Review.Vaccines (Basel). 2025 Apr 25;13(5):460. doi: 10.3390/vaccines13050460. Vaccines (Basel). 2025. PMID: 40432072 Free PMC article. Review.
-
Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States.Hum Vaccin Immunother. 2021 Dec 2;17(12):5390-5396. doi: 10.1080/21645515.2021.1989919. Epub 2021 Nov 4. Hum Vaccin Immunother. 2021. PMID: 34736353 Free PMC article.
-
There's Much Yet to be Done: Diverse Perspectives on HPV Vaccination.Hum Vaccin Immunother. 2019;15(7-8):1459-1464. doi: 10.1080/21645515.2019.1640559. Hum Vaccin Immunother. 2019. PMID: 31365327 Free PMC article. Review. No abstract available.
-
Aligning healthcare, public health and social services: A scoping review of the role of purpose, governance, finance and data.Health Soc Care Community. 2022 Feb;30(2):432-447. doi: 10.1111/hsc.13374. Epub 2021 May 20. Health Soc Care Community. 2022. PMID: 34018268 Free PMC article.
References
-
- Centers for Disease Control and Prevention How many cancers are linked with HPV each year? Atlanta (GA): Division of Cancer Prevention and Control; 2018. August 15 [accessed 2018October12]. http://www.cdc.gov/cancer/hpv/statistics/cases.htm
-
- Centers for Disease Control and Prevention Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2011;60(50):1705–08. - PubMed
-
- Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE.. Centers for disease control and prevention. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64:300–04. - PMC - PubMed
-
- Centers for Disease Control and Prevention For parents of preteens and teens: vaccines for your children. Atlanta (GA): National Center for Immunization and Respiratory Diseases; 2016. April 1 [[accessed 2018October12]. https://www.cdc.gov/vaccines/parents/diseases/teen/index.html
-
- The Henry J. Kaiser Family Foundation The HPV vaccine: access and use in the U.S. San Francisco (CA): The Henry J. Kaiser Family Foundation; 2018. [accessed 2018 October12October9]. http://kff.org/womens-health-policy/fact-sheet/the-hpv-vaccine-access-an...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical